Pharma Brands Must Connect Clinician and Patient Recall

Pharma brand building is solving two different problems at once. But most briefs don't acknowledge that. For HCPs, a brand needs to be a retrieval cue. For patients, it needs to be an identity signal. Those aren't the same job, and treating them as one is why "matching luggage" creative often falls flat. My new piece on what it actually means to build brand recall in pharma. And why someone opening your medicine cabinet at a dinner party has something to teach us about it. https://lnkd.in/epDnU6XZ

In pharma, when the Marketing Head asks the brand manager why the promo material is not yet dispatched, the answer is almost always the same. 'Internal approval is taking time.' It is the most useful sentence in pharma marketing. Not because it is true. Most of the time, it is partly true. But because it stops the conversation. Marketing Head accepts it. Brand manager moves on. Two weeks later, when the same question comes up again, the same sentence works again. Nobody asks the next question. The question is simple. 'How many times has this visual aid gone back for changes?' In PMT review meetings across pharma, that question almost never gets asked. That question changes everything. Because the honest answer, three or five or eleven, opens up a different conversation. Not about how slow medical are. About how many of those rounds could have been avoided before the first draft was even sent. The claim that was not properly supported. The reference that was three years out of date. The copy that no doctor would actually believe. The visual that medical was guaranteed to flag. Every one of these is easy to spot on day one. None of them are caught on day one. Not because the brand manager is careless, but because the brand manager is alone. There is no role in the team whose job it is to ask, 'will this survive medical, regulatory and legal?', before the visual aid leaves the desk. So the brand manager keeps moving. The next deck, the next campaign, the next quarterly review. And the rejection rounds keep arriving. So the same visual aid goes back. And back. And back. Each round, one campaign date moves by ten days. Across a portfolio of ten brands, each going through three to five rounds a year, that is months of brand momentum lost every year. None of it shows up in any cost sheet. All of it shows up in the next quarter's shortfall conversation. The fix is not pushing medical, regulatory and legal to move faster. The fix is fewer rounds. Because the risks were caught before the first draft went out. That work happens before the visual aid ever leaves the brand manager's desk. It is the cheapest fix in pharma marketing. And almost nobody is doing it.

Your brand can be famous and still not be prescribed. That’s one of the hardest truths in pharma marketing. A doctor may know your brand. They may have seen it at global conferences. They may believe it is high quality. They may even know it is the innovator brand. And yet, when the patient is sitting in front of them… They still write the competitor. Why? Because recall is not the same as behavior change. In mature therapy categories, especially chronic ones, the winning brand is often not the one with the loudest communication. It is the one that has solved a real problem for the doctor. A titration problem. A patient-flow problem. A trust problem. A convenience problem. A habit problem. That is why top-of-funnel campaigns can feel good but fail commercially. More emails. More webinars. More impressions. More visibility. But no meaningful change in prescription behavior. The real question is not: “How do we increase brand recall?” The real question is: “What has to happen for this doctor to write this brand every month?” That shift changes the entire strategy.

After 30 years in healthcare brand marketing, here’s the simplest truth I’ve learned: HCPs are humans first 🤯 It sounds obvious but our industry forgets it—again and again. We want to drive recommendation rates so we build campaigns for the rational clinician: data-heavy, detail-rich, logically watertight. And yet, in the real world, decisions are made: 👉 Under time pressure 👉 With incomplete information 👉 Through habit and experience 👉 Filtered by emotion, confidence, and risk In other words—humanly. If you want to drive recommendation, it’s not just about: ✔️ What do they need to know? It’s about: ✔️ What’s getting in the way of them acting? The friction points—cognitive overload, habit, risk aversion—don’t get solved by adding more data. They get solved by making decisions easier, more intuitive, and more human. Design for: System 1 → fast, instinctive, easy to recall System 2 → rational, evidence-based, defensible Win both, and behaviour changes. Miss one, and it doesn’t. The best healthcare brands don’t just communicate clinical value. They connect with the human making the decision. Not instead of science—but alongside it. Because in the end: scientific proof earns consideration…but human understanding earns ACTION. If your healthcare brand wants to shift recommendation rates, get in touch

Brand awareness isn’t enough in healthcare marketing. If a patient sees your ad, visits your website, or hears your brand name but still doesn’t understand why they need the service, why they should trust you, or what makes your experience different… then the marketing either didn’t do its job or it stopped too early. The real work happens before the first appointment. Especially if the goal is to not only attract new patients but keep them coming back. Especially in healthcare, veterinary care, dental, or any service built on doctor-patient trust. People aren’t just buying convenience, they’re looking for reassurance. They want to know, “Will I be cared for?”, “Is this provider credible?”, “Will this team make me feel comfortable?”, “Do they understand my concerns?”. That’s why education matters just as much as visibility. The strongest brands don’t just create awareness, they reduce uncertainty. And in multi-location organizations, that challenge becomes even more important. Because EVERY location has to consistently communicate trust while still feeling human and local to its community. The best-performing healthcare brands build confidence long before the appointment is scheduled. And this work sets them up for success during the first appointment, and beyond.

Most healthcare brands spend millions on campaigns that physicians/patients forget before the presenter/representative/marketer leave the clinic/meeting room. Here's the uncomfortable truth: You don't have a reach problem. You have a RELEVANCE problem. In healthcare marketing, there's a principle we call the "White Coat Illusion" — the belief that clinical credibility alone builds brand trust. It doesn't. Patients don't remember your efficacy data. They remember how your brand made them feel. Physicians don't remember the clinical trials numbers/percentages/publishing dates They remember how your brand improved his patient's life The most powerful healthcare brands in the world have cracked this code: → They lead with empathy, not authority. → They speak in human language, not medical jargon. → They show up consistently in the moments that matter — not just at product launch. → They treat the patient journey as a narrative, not a transaction. This is the gap we see most often when brands come to us. A technically brilliant product — wrapped in communication that speaks to doctors, not to the human being sitting in the waiting room. Patient centricity isn't a buzzword to put in your brand guidelines. It's a discipline. A strategic choice. A complete reorientation of how you build every message, every visual, every touchpoint. When you get it right, the tipping point happens. Little actions — a better-written leaflet, a more honest campaign, a more human digital experience — create a big impact on trust, adherence, and brand loyalty. What's one healthcare brand you think truly nails patient-centric communication? Drop it in the comments — we'd love to see who's setting the bar. 👇 follow the tipping point for more liked the content, click like :) https://www.ttphcc.com

If your brand disappeared tomorrow, who would genuinely notice? In healthcare, that’s not a philosophical question. It’s a commercial one. Campaigns launch. Assets roll out. Portals fill up. Most of it is compliant. Much of it is competent. Very little of it is missed when it stops. Someone once asked me whether our agency would leave a gap if we vanished. It wasn’t comfortable. Because activity isn’t the same as impact and presence isn’t the same as preference. In regulated categories where claims are tightly aligned, distinctiveness is one of the few remaining growth levers. If your brand isn’t shaping the conversation in the room, it’s probably just adding to it. That shifted something for me. I don’t want us measured by volume. I want us measured by whether the work changes the quality of discussion between rep and HCP. Whether it sharpens positioning. Whether it gives a team more confidence to lead. If nothing changes when you remove the brand, it wasn’t strategically sharp enough to begin with. That’s become a filter for us. When you look at your portfolio, which brands are genuinely influencing behaviour and which are simply present?

EVERSANA INTOUCH's 4th Annual Brand Planning Report uncovers persistent gaps pharma marketing executives face: efficiency, consistency, and the ability to harness data effectively. With input from industry leaders, the report explores the state of brand planning and how AI-powered integration can address these challenges. See the findings: https://lnkd.in/eWuXF764

Brand Management in B2B is not what most people think it is In B2C, brand often lives in storytelling, emotion, and visibility. In B2B, too many people assume brand is secondary — something that sits on top of product, sales, or demand generation. That’s a mistake. In B2B, brand is not decoration. It is a decision infrastructure. It shapes how buyers think when: • The sales cycle is 6–18 months • Multiple stakeholders are involved • Risk is higher than reward • Products are complex and often similar on paper In that environment, brand is what reduces uncertainty. Strong B2B brand management means: 🧭 Clarity over complexity If your positioning cannot be explained in one simple “why us,” you lose before the conversation even starts. 🏗️ Consistency across every touchpoint From sales decks to product UI to customer success — inconsistency creates doubt, and doubt kills deals. 🧠 Deep buyer understanding (not just personas) You’re not selling to “industries.” You’re selling to humans with pressure, KPIs, and internal politics. 📊 Linking brand to revenue outcomes Awareness alone is not enough. Brand must influence pipeline quality, conversion, and retention. 🤝 Alignment between marketing, product, and sales In B2B, brand fails when teams tell different stories to the same buyer. The best B2B brands don’t just look credible. They remove friction from buying decisions. And in complex categories, that is the real competitive advantage. Because in the end, buyers don’t choose the “best” option. They choose the option that feels safest to defend internally. That’s what brand does in B2B.

This Mother’s Day, healthcare and pharma brand managers focused on driving growth through brand extensions should remember to strengthen the “Mother Brand” too—because when the core brand weakens, the entire brand architecture suffers, leading to fragmented equity, inefficient promotions, and lower ROI. Welcoming comments from seasoned marketers.